Daniël M Miedema

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Cancer Stem Cells

Mitochondrial Dna

Prognostic Factors

Top Venues

Nature protocols

The Journal of pathology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tom van den Bosch, Sarah Derks, Daniël M Miedema
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity. Cancers 14 (20) (2022)
Tom van den Bosch, Daniël M Miedema, Louis Vermeulen
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer † . The Journal of pathology 257 (5) (2022)
Tom van den Bosch, Oscar M Rueda, Carlos Caldas, Louis Vermeulen, Daniël M Miedema
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy. British journal of cancer 127 (7) (2022)
Tom Van Den Bosch, Erik van Dijk, Louis Vermeulen, Daniël M Miedema
Predicting survival of cancer patients by chromosomal copy number heterogeneity. Molecular & cellular oncology 8 (4) (2021)
Erik van Dijk, Tom van den Bosch, Kristiaan J Lenos, Khalid El Makrini, Lisanne E Nijman, Hendrik F B van Essen, Nico Lansu, Michiel Boekhout, Joris H Hageman, Rebecca C Fitzgerald, Cornelis J A Punt, Jurriaan B Tuynman, Hugo J G Snippert, Geert J P L Kops, Jan Paul Medema, Bauke Ylstra, Louis Vermeulen, Daniël M Miedema
Chromosomal copy number heterogeneity predicts survival rates across cancers. Nature communications 12 (1) (2021)
Kristiaan J Lenos, Sophie C Lodestijn, Scott K Lyons, Maarten F Bijlsma, Daniël M Miedema, Louis Vermeulen
A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue. Nature protocols 14 (9) (2019)